125 related articles for article (PubMed ID: 1857350)
1. Theoretical analysis of the accuracy of calibrated immunoassays for measuring antibody concentration.
Griswold WR; Chalquest RR
Mol Immunol; 1991 Jul; 28(7):727-32. PubMed ID: 1857350
[TBL] [Abstract][Full Text] [Related]
2. The importance of antibody affinity in the performance of immunoassays for antibody.
Steward MW; Lew AM
J Immunol Methods; 1985 Apr; 78(2):173-90. PubMed ID: 2580911
[No Abstract] [Full Text] [Related]
3. The effect of variance function estimation on nonlinear calibration inference in immunoassay data.
Belanger BA; Davidian M; Giltinan DM
Biometrics; 1996 Mar; 52(1):158-75. PubMed ID: 8934590
[TBL] [Abstract][Full Text] [Related]
4. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.
Findlay JW; Smith WC; Lee JW; Nordblom GD; Das I; DeSilva BS; Khan MN; Bowsher RR
J Pharm Biomed Anal; 2000 Jan; 21(6):1249-73. PubMed ID: 10708409
[TBL] [Abstract][Full Text] [Related]
5. Method of analysis of non-competitive enzyme immunoassays for antibody quantification.
Beatty JD; Beatty BG; Vlahos WG; Hill LR
J Immunol Methods; 1987 Jun; 100(1-2):161-72. PubMed ID: 3298436
[TBL] [Abstract][Full Text] [Related]
6. Significant reduction of the bias among commercial immunoassays for lipoprotein(a) after use of a uniform calibrator.
Lippi G; Lo Cascio C; Ruzzenente O; Brentegani C; Guidi G
Clin Chim Acta; 1996 Dec; 256(2):125-34. PubMed ID: 9027424
[TBL] [Abstract][Full Text] [Related]
7. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies.
Fontaine M; Homburger HA; Nichols WL
Thromb Haemost; 2001 Oct; 86(4):1123-4. PubMed ID: 11686339
[No Abstract] [Full Text] [Related]
8. The immunoassay of cytokines and growth factors in biological fluids.
Kopp W; Reynolds C; Ruscetti F
Dev Biol Stand; 1999; 97():29-37. PubMed ID: 10463528
[TBL] [Abstract][Full Text] [Related]
9. Cytokine immunoassays: recommendations for standardisation, calibration and validation.
Wadhwa M; Thorpe R
J Immunol Methods; 1998 Oct; 219(1-2):1-5. PubMed ID: 9831384
[TBL] [Abstract][Full Text] [Related]
10. A method for the determination of antibody affinity using a direct ELISA.
Schots A; Van der Leede BJ; De Jongh E; Egberts E
J Immunol Methods; 1988 May; 109(2):225-33. PubMed ID: 3361133
[TBL] [Abstract][Full Text] [Related]
11. Application of recovery tests in the validation of immunoassays for assessing the immunogenicity of B. anthracis PA vaccine.
Halperin G; Marcus H
PDA J Pharm Sci Technol; 2001; 55(3):150-61. PubMed ID: 11417105
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
Stubenrauch K; Wessels U; Lenz H
J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
[TBL] [Abstract][Full Text] [Related]
13. Testing homogeneity of intra-run variance parameters in immunoassay.
Zeng Q; Davidian M
Stat Med; 1997 Aug; 16(15):1765-76. PubMed ID: 9265699
[TBL] [Abstract][Full Text] [Related]
14. The influence of epitope density on the estimation of the affinity of antibody for complex antigens.
Holland GP; Steward MW
J Immunol Methods; 1991 Apr; 138(2):245-55. PubMed ID: 1709667
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics.
Gupta S; Indelicato SR; Jethwa V; Kawabata T; Kelley M; Mire-Sluis AR; Richards SM; Rup B; Shores E; Swanson SJ; Wakshull E
J Immunol Methods; 2007 Apr; 321(1-2):1-18. PubMed ID: 17307199
[TBL] [Abstract][Full Text] [Related]
16. Diisocyanate conjugate and immunoassay characteristics influence detection of specific antibodies in HDI-exposed workers.
Campo P; Wisnewski AV; Lummus Z; Cartier A; Malo JL; Boulet LP; Bernstein DI
Clin Exp Allergy; 2007 Jul; 37(7):1095-102. PubMed ID: 17581205
[TBL] [Abstract][Full Text] [Related]
17. Interference in immunoassays to support therapeutic antibody development in preclinical and clinical studies.
Schwickart M; Vainshtein I; Lee R; Schneider A; Liang M
Bioanalysis; 2014; 6(14):1939-51. PubMed ID: 24806787
[TBL] [Abstract][Full Text] [Related]
18. Vailidation of immunoassays for anti-drug antibodies.
Van Cleave VH
Dev Biol (Basel); 2003; 112():107-12. PubMed ID: 12762509
[TBL] [Abstract][Full Text] [Related]
19. Antidrug antibody assay validation: industry survey results.
Gorovits B
AAPS J; 2009 Mar; 11(1):133-8. PubMed ID: 19255857
[TBL] [Abstract][Full Text] [Related]
20. Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in Patients.
Darrouzain F; Bian S; Desvignes C; Bris C; Watier H; Paintaud G; de Vries A
Ther Drug Monit; 2017 Aug; 39(4):316-321. PubMed ID: 28570370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
